Efstathios N Stathopoulos Selected Research

Drug Therapy (Chemotherapy)

1/2011	Detection of the TNFSF members BAFF, APRIL, TWEAK and their receptors in normal kidney and renal cell carcinomas.
7/2008	Interferon-alpha inhibits proliferation and induces apoptosis of merkel cell carcinoma in vitro.
9/2002	The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Efstathios N Stathopoulos Research Topics

Disease

25	Neoplasms (Cancer) 01/2020 - 09/2002
12	Breast Neoplasms (Breast Cancer) 01/2020 - 07/2005
6	Prostatic Neoplasms (Prostate Cancer) 04/2013 - 09/2002
5	Carcinoma (Carcinomatosis) 01/2012 - 01/2003
4	Multiple Myeloma 01/2020 - 10/2006
3	Neoplasm Metastasis (Metastasis) 01/2019 - 09/2010
3	Merkel Cell Carcinoma 04/2011 - 07/2008
3	Hyperplasia 04/2008 - 01/2003
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 08/2007
2	Inflammation (Inflammations) 01/2013 - 02/2012
2	Triple Negative Breast Neoplasms 08/2012 - 02/2011
2	Circulating Neoplastic Cells 05/2009 - 11/2007
2	Hypoxia (Hypoxemia) 01/2009 - 10/2007
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2005 - 11/2004
1	Melanoma (Melanoma, Malignant) 09/2017
1	Lung Injury 01/2014
1	Malignant Mesothelioma 07/2013
1	Mesothelioma 07/2013
1	Carcinogenesis 04/2013
1	Lung Neoplasms (Lung Cancer) 04/2013
1	Glioma (Gliomas) 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 11/2012
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2012
1	Colitis 06/2012
1	Septic Shock (Toxic Shock Syndrome) 06/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2012
1	Burns 02/2011
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 02/2011
1	Blister (Bulla) 02/2011
1	Eosinophilic pustular folliculitis 02/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2011
1	Endometrial Hyperplasia 12/2010
1	Lymphoma (Lymphomas) 01/2009
1	Hodgkin Disease (Hodgkin's Disease) 01/2009
1	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2008

Drug/Important Bio-Agent (IBA)

8	LigandsIBA 01/2020 - 03/2008
7	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 02/2005
7	Proteins (Proteins, Gene)FDA Link 01/2014 - 02/2005
7	Testosterone (Sustanon)FDA Link 04/2011 - 09/2002
5	AndrogensIBA 01/2019 - 01/2003
4	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2020 - 02/2012
4	CytokinesIBA 01/2014 - 03/2008
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 04/2008
3	Estrogen ReceptorsIBA 01/2019 - 10/2007
3	Estrogen Receptor alphaIBA 01/2019 - 02/2011
3	MicroRNAs (MicroRNA)IBA 01/2014 - 02/2011
3	Biological ProductsIBA 02/2013 - 07/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 03/2008
2	Phosphotransferases (Kinase)IBA 01/2019 - 04/2013
2	Transcription Factors (Transcription Factor)IBA 02/2013 - 08/2012
2	angiogeninIBA 09/2012 - 01/2005
2	Interleukin-6 (Interleukin 6)IBA 09/2012 - 11/2004
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2012 - 10/2007
2	Stem Cell FactorIBA 04/2011 - 01/2009
2	InterferonsIBA 02/2011 - 07/2008
2	Keratin-19 (Keratin 19)IBA 05/2009 - 11/2007
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2009 - 11/2007
2	Messenger RNA (mRNA)IBA 05/2009 - 11/2007
2	SteroidsIBA 10/2007 - 07/2005
2	ParaffinIBA 08/2007 - 11/2005
1	Protein Isoforms (Isoforms)IBA 01/2019
1	EpitopesIBA 01/2019
1	AntibodiesIBA 01/2019
1	Protein Kinase CIBA 09/2017
1	AcidsIBA 01/2014
1	Hydrochloric Acid (Hydrogen Chloride)FDA Link 01/2014
1	AsbestosIBA 07/2013
1	Interleukin-8 (Interleukin 8)IBA 07/2013
1	Urethane (Ethyl Carbamate)IBA 04/2013
1	Phenobarbital (Luminal)FDA Link 02/2013
1	Cyclin D1IBA 02/2013
1	ElementsIBA 02/2013
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2012
1	platelet-derived growth factor ABIBA 09/2012
1	RNA (Ribonucleic Acid)IBA 08/2012
1	Dextran SulfateIBA 06/2012
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2012
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2012
1	Hormones (Hormone)IBA 04/2011
1	taxaneIBA 04/2011
1	proanthocyanidinIBA 04/2011
1	Proanthocyanidins (Procyanidins)IBA 04/2011
1	Peptides (Polypeptides)IBA 02/2011
1	perforin-granzyme BIBA 02/2011
1	antalarminIBA 09/2010
1	CateninsIBA 09/2010
1	B-Cell Activating FactorIBA 11/2009
1	Caspase 3 (Caspase-3)IBA 01/2009
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2009
1	Platelet-Derived Growth Factor alpha ReceptorIBA 01/2009
1	Interferon-alpha (Interferon Alfa)IBA 07/2008

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2011 - 09/2002
2	Therapeutics 02/2013 - 04/2011
2	Adjuvant Chemotherapy 05/2009 - 11/2007
1	Biological Therapy 01/2020
1	Castration 04/2013
1	Immunotherapy 01/2011
1	Curettage 12/2010
1	Hysterectomy 12/2010